chrisvoncsefalvay/vaers-outcomes huggingface dataset:
10:00 am - headache 2/18 1:56am - temp of 100.2 Given Tylenol & lidocaine cream
A male patient (age not specified), with no illness at the time of vaccination, had received a first dose, intramuscular, left deltoid injection of Adacel, lot number C2690AA, on 12 June 2007. At an unspecified amount of time post-vaccination, the patient experienced a temperature of 102.0 degrees Fahrenheit, severe swollen glands in the right neck, and aches which lasted for five days. It was also reported that he experienced a swollen left knee eight days following vaccination. Diagnostic testing was none. The patient recovered from the event. The reporter in this case is the same as in case 2007-02489, 2007-02495, 2007-02496, 2007-02497, and 2007-02498.
my eyes have been puffy; my vision was kind of weird.; I've also felt fatigued; numbing that went from  jawline /earlobe up to face, across cheek.; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbing that went from  jawline /earlobe up to face, across cheek.), PERIORBITAL SWELLING (my eyes have been puffy), VISUAL IMPAIRMENT (my vision was kind of weird.) and FATIGUE (I've also felt fatigued) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), EZETIMIBE (ZETIA) and METOPROLOL for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced HYPOAESTHESIA (numbing that went from  jawline /earlobe up to face, across cheek.). On an unknown date, the patient experienced PERIORBITAL SWELLING (my eyes have been puffy), VISUAL IMPAIRMENT (my vision was kind of weird.) and FATIGUE (I've also felt fatigued). On 10-Feb-2021, HYPOAESTHESIA (numbing that went from  jawline /earlobe up to face, across cheek.) had resolved. At the time of the report, PERIORBITAL SWELLING (my eyes have been puffy) and VISUAL IMPAIRMENT (my vision was kind of weird.) outcome was unknown and FATIGUE (I've also felt fatigued) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Follow-up received on 29-April-2021 contains non-significant information. Contact information was updated.
The next morning of my vaccination i had a lymph node and pain in my shot arm. i had chest tightness. After noon i took my pulse and it was really strong. I was worried and went to the urgent care and they gave me Tylenol and did an ekg and the pulse was down to 90. The doctor feel my pulse skip twice. My temperature was really high when i left the house. When i went home from the urgent care i felt much better my fever was down and my pulse was better as well. I went to bed but the fever was back so i had to get over the counter medication. Couple of days later i had hives.
Entire top part of arm was red swollen and hot. Fever of 103 lasting 2 days.
Mild tingling around both eyes,  after the booster on  Saturday, 09/25/2021. On 09/26/2021, a mild rash appeared on the skin around my eyes. The tingling sensation turned into burning. Treated it with steroid cream I had for something else, which seemed to partially quell the rash. But by a full week after the booster, on 10/02/2921, the rash became bright red, itched and burned, and traveled down both cheeks, with a patch appearing in the thyroid area of my neck. On the night of Saturday, 10/02/2021, I stopped the topical steroid cream. I switched to the maximum daily dosage of Benadryl and slathering the affected areas with aloe.  By the next day, Sunday, 10/03/2021 there was a marked improvement. Today, Monday 10/04/2021, the rash and discomfort is @ 95% resolved. I have photos, if you need them. My MD has them too?from which he suggested an adverse reaction to the booster.
Prolonged sleepiness, Lethargy, confusion, pupil constriction, abnormal response to stimulus.
Received ROTARIX 0.5ml IM- diluted with sterile diluent for manufacturer live virus vaccine (steril water)
Area vaccinated warm to touch, swelling, itching, redness, fever, vomitting, soreness.
Patient had pfizer covid shot 05/10. starting 5/11 patient experienced pruritis and redness around injection site. also described it as swollen and painful. injection in left deltoid.
Initial and follow-up information has been received through the Merck Pregnancy registry from a registered nurse a 17 year old white female with bipolar disorder, headache, and no previous pregnancies, who on 02-JUL-2007 was vaccinated IM with a 0.5 ml first dose of Gardasil (lot # 655617/1447F). Concomitant therapy included XANAX. On 02-JUL-2007, after the vaccination, a urine beta-human chorionic gonadotropin test was reported positive for pregnancy. The patients last menstrual period was 24-MAY-2007. The estimated date of delivery was 02-MAR-2008. On 19-JUL-2007, at 8 weeks from the last menstrual period, the patient had an elective termination of the pregnancy. The patient was scheduled to return for her second dose of Gardasil on 10-SEP-2007. Upon internal review, elective termination was considered to be an other important medical event. Additional information is not expected.
soreness at injection site for several days and 10 days after receiving the shot I developed a circular red rash around the injection shot that was slightly itchy for a short time. The rash is still there as of today.
Unforeseen adverse medical side effects suffered as a result of my vaccination on 06/8/22; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (Unforeseen adverse medical side effects suffered as a result of my vaccination on 06/8/22) in a male patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 037A22B) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 in 2021.    On 08-Jun-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Unforeseen adverse medical side effects suffered as a result of my vaccination on 06/8/22). At the time of the report, IMMUNISATION REACTION (Unforeseen adverse medical side effects suffered as a result of my vaccination on 06/8/22) had not resolved.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  The patient's PCP advised him to hold any further vaccinations until all medical issues had resolved. Treatment information was not provided.   Reporter did not allow further contact
IPOL after it was mistaken for PPD test and administered as 0.1 mL intradermally with no adverse event; Initial information received on 15-Aug-2023 regarding an unsolicited valid non-serious case received via other health professional.  This case involves a 79-year-old male patient, IPV (VERO) [IPOL] after it was mistaken for ppd test and administered as 0.1 ml intradermally with no adverse event.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.  On 14-Aug-2023, the patient received a 0.1 ml dose of suspect IPV (VERO) Suspension for injection (strength: unknown) (lot: W1A101M, 10-Feb-2025) via intradermal route in unknown administration site for Immunization and ipol after it was mistaken for ppd test and administered as 0.1 ml intradermally with no adverse event (wrong product administered) (latency: same day).  It was unknown if any lab data/test results available.  Action taken with POLIOMYELITIS VACCINE (INACTIVATED) (IPOL) was not applicable.  Outcome: Unknown    This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
irregular heart beats, and Chest pain.  lasted three days, intermittent; checked heart rate by machine 130's - 140's.  gone by taking Advil.
Within about 15 minutes of administration of the 2nd dose of the Pfizer COVID vaccine, the patient experienced arm numbness / tingling that radiated between the elbow and her hand.
Patient became cool, clammy, and pale. Started snoring heavily and slumped forward with eyes opened. He began seizing and convulsing which lasted approximately 15 seconds and then slowly came to.
Pt describes a soreness in injection arm which has persisted since 12/16/11.
This spontaneous report was received from a healthcare worker refers to a 16 year old male patient. On 19-OCT-2012, the patient was vaccinated with first dose of GARDASIL, (lot number, expiry date and route was not reported). On 26-DEC-2012, the patient was vaccinated with second dose of GARDASIL, (lot number, expiry date and route was not reported). On 01-APR-2013, the patient was vaccinated with their dose of GARDASIL, (lot number, expiry date and route was not reported). Concomitant medications were not reported. The patient got his GARDASIL doses a little bit early. No adverse event was reported. Additional information is not expected.
Patient was incorrectly given the Pediatric Monovalent Pfizer vaccine instead of the Pediatric Bivalent Pfizer vaccine. No adverse reaction(s) were reported by patient's mother. Patient has to wait at least 2 months to receive the correct Bivalent dose.
had a rash at the injection site; felt ill for a day; This case was reported by a consumer and described the occurrence of malaise in a 63-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced malaise and injection site rash. On an unknown date, the outcome of the malaise and injection site rash were recovered/resolved.   It was unknown if the reporter considered the malaise and injection site rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient felt ill for a day and had a rash at the injection site. This case has been linked to US2020AMR042562 and US2020AMR042566, reported by the same reporter. This case has been linked to the case US2020AMR042562, reported for the same patient (2nd dose).
Infection on injection site. Treatment by MD; cephalexin 500mg 2 bid for 10d. On injection site on PREVNAR 13 - (R) delt.
I experienced mainly a strong headache. I waited until approximately 24 hours after the shot to take anything for it. I treated with OTC pain reliever OTC extra strength Tylenol 500MG x 2. Repeated this approx 6 hours later again taking 500MG x2. After 2 doses I felt good enough and discontinued taking anything beyond that.
Sore arm, red at shot area, tongue & lips swollen, sore glands on left side of neck, tired, but no temp or upset stomach. Still some numbness as of Monday 4/12/2021.
7 1/2 x 7 cm non indurated redness on left deltoid, surrounding DTaP and MMR vaccine site plus itching. Treated with Zyrtec and cool compresses.
Quarter sized red circle at injection site, slightly itchy - 1/24 at 8:00 pm Circle became larger (two inch diameter) morning of 1/25; itches a little bit more.  Slightly warm to touch.
Sudden unilateral hearing loss on the left ear. Currently taking a 14 day dose of oral predisone, had one transtympanic injection of steroids, have had 2 audiograms. Plan to start hyperbaric oxygen treatments and have more injections and audiograms. No improvement to date.
Patients brother reported shortly after leaving office patient became unresponsive for five to ten seconds. Brother drove patient back to office. On exam patient was alert and oriented times three. Reports that she had remembered feeling sleepy prior to event and thought when she came to that she was at home.  911 was called to the scene. Patient/brother denied EMS transport to hospital.
Swelling, soreness and redness from injection site to just above my elbow.  Took ibuprofen and iced for 10 minutes at a time
Day after injection (4/17) arm was swollen, red and hot to touch. By 4/19 patient had hives on stomach/trunk area which is the same way her previous drug allergies presented. She called her Dr. and Dr. said the SHINGRIX was the likely cause of the reaction.
Information regarding poliovirus vaccine live oral trivalent solution was received from an attorney regarding a deceased female who received a dose on an unspecified date. Relevant medical history was not provided. Indication for Orimune vaccine was immunization. Product was administered on an unspecified date. Dose regimen was not provided. Concomitant medications were not reported. An attorney alleges that the polio vaccine received by the decedent contained a harmful prohibited animal virus known as Simian Virus 40 (SV40). The attorney also alleges that the decedent became ill with Simian Virus 40 -related disease, including malignant brain cancer, and subsequently died on 1/26/02. No additional information was available at the time of this report.
Pt had severe vasovagal response within 2-3 minutes of administration, BP dropped 77/46 HR 41, to 84/64 HR 51 for more than 15 minutes, nausea. Patient remained conscious and responsive. EMS was activated, they monitored for 15 minutes, BP stabilized. Patient declined to go to ER.
Swollen lymph node on collarbone; painful lymph nodes on collarbones; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot number: unknown), via an unspecified route of administration and anatomical site on 24Mar2021 at 12:30 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included thyroid cancer and blood pressure high. The patient did not have allergies to medications, food, or other products. No concomitant medications were taken by the patient. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021, the patient experienced swollen lymph node and painful lymph nodes on collarbone. The patient did not receive any treatment for the events. The clinical outcome of the event swollen lymph node and painful lymph nodes was not recovered at the time of report.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
36 hrs p/vax pt devel red splotchy hive-like rash w/itching; treated by MD w/DPh-rash resolved; no fever & no other sx; father stated laundry detergent had been changed;
feel like I have been run over by a truck; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feel like I have been run over by a truck) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (feel like I have been run over by a truck). At the time of the report, FEELING ABNORMAL (feel like I have been run over by a truck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was unknown by the reporter. Treatment information was not provided
In the evening of 8/2/00, the pt's mother noticed erythema on her left leg in the area the injection was given. By 8/3/00, the area had enlarged to the size of an orange with bruising noted in the center, edema of the toes was present. Physician was consulted and the pt was placed on oral antibiotics. On 8/5/00, the pt's mother stated the redness had extended down the pt's leg and the area involved was hard when palpated. The pt was taken to the hospital for in-pt IV antibiotic therapy. The pt was released on 8/7/00. Follow-up with pediatrician on 08/28/00. From follow-up info received on 10/05/00, it was reported, "Reviewed, no additional info at this time." From follow-up info received on 03/16/01, reported by phone, pt did well during two day hospitalization. Follow-up 05/14/02, during internal audit of all files, it was deemed necessary to amend the report by updating adverse event coding (added edema). The case is closed.
Soreness in left shoulder that started 10 minutes after receiving injection. Shoulder soreness never went away. I scheduled a follow up with the workplace medical clinic and they took an x-ray and sent me for an MRI to be complete. They noted inflammation in the left deltoid from the MRI. I attended multiple physical therapy sessions which made the problem worse. I scheduled another follow-up with the workplace medical clinic and the referred me to an orthopedic specialist on 6/29/2022. Soreness is still persistent and causing pain 6+ months after receiving the booster.
Information has been received from a healthcare worker (immunization official) referring to a 23 month old patient. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 06-JUL-2015, the patient was vaccinated with a dose of (Oka/Merck) VARIVAX, lot # K010440 (expiration date, dose and route not reported), which was improperly stored. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
pt recv vax 10OCT95 & 1yr later lab titers were drawn which indicated pt was non-immune;
Pt stated that she had redness, itching and swelling day after influenza administration. She stated that she had it last year (2016-2017) as well despite different mfr. States No Egg Allergy.
Fever, Lethargy, progressing to post vaccine vzv with generalized rash/ crusting lesions over whole body.
We have some Moderna Covid-019 vaccine that was given after the expiration date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     No Medical History information was reported.    In October 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.). In October 2021, EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   4 vials with 44 doses were initially stored in the refrigerator on 24-SEP-2021 and did not undergo any temperature excursion. Dosing was done between 24Oct2021 - 27Oct2021. No concomitant medications were provided. No treatment medications were provided.
redness on my arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness on my arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (redness on my arm). At the time of the report, ERYTHEMA (redness on my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
all tests came back positive for COVID-19 / diagnosed with COVID-19 infection; lack of drug effect; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (all tests came back positive for COVID-19 / diagnosed with COVID-19 infection) and DRUG INEFFECTIVE (lack of drug effect) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939905, 031L20A and 027A21A) for COVID-19 vaccination.     Previously administered products included for Drug use for unknown indication: flu shot in October 2021. Past adverse reactions to the above products included No adverse event with flu shot. Concurrent medical conditions included Type II diabetes mellitus. Concomitant products included LIRAGLUTIDE (VICTOZA), METFORMIN, SIMVASTATIN, LISINOPRIL and INSULIN DETEMIR (LEVEMIR) for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Jan-2022, the patient experienced COVID-19 (all tests came back positive for COVID-19 / diagnosed with COVID-19 infection) and DRUG INEFFECTIVE (lack of drug effect). At the time of the report, COVID-19 (all tests came back positive for COVID-19 / diagnosed with COVID-19 infection) and DRUG INEFFECTIVE (lack of drug effect) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jan-2022, SARS-CoV-2 test: positive (Positive) Positive.         Patient went to urgent care for an additional COVID-19 tests and was positive. No treatment information was provided.; Sender's Comments: This is a spontaneous case concerning a 66-year-old, female patient with a history of Type 2 diabetes, who was diagnosed with COVID-19 a month after receiving the booster dose of mRNA1273. Primary vaccination was also completed with Moderna product, with an appropriate schedule, which characterizes a lack of effect of the vaccine. The benefit-risk relationship of mRNA-1273 in not affected by this report.
Developed a small lump at the injection site and a mark on the skin that resembles a bruise. It is sore to touch and when moving arm or laying on it. I had the vaccine 3 weeks ago and had no side effects other than a slight sore arm.
Red area (60 mm) at site; warm to touch and tender to touch.  Firm feeling (10 mm) at injection site.  States was puffy looking on 8/26 and 8/27/08.  Temp 97.3.